関連ニュース

Camp4 Therapeutics Corporation (CAMP) Analyst/Investor Day Transcript

Vancouver, British Columbia – TheNewswire - August 31, 2026 — Canadian GoldCamps Corp. (CSE: CAMP) (OTC: SMATF) (FSE: A68) (“ Canadian GoldCamps ” or the “ Company ”) announces that, further to its ne

Achieving Key Regulatory Milestone and Positioning the Company for its Next Phase of Growth Vancouver, British Columbia – TheNewswire - July 28, 2026 — Canadian GoldCamps Corp. (CSE: CAMP) (OTC: SMATF

CAMBRIDGE, Mass., July 17, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regula

CAMBRIDGE, Mass. , July 17, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation ("CAMP4" or "the Company") (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regul